 Sarah Gitomer
Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinitis | 4 | 2022 | 169 | 1.510 |
Why?
| | Congenital Microtia | 4 | 2025 | 8 | 1.480 |
Why?
| | Olfaction Disorders | 2 | 2023 | 74 | 1.450 |
Why?
| | Sinusitis | 4 | 2022 | 230 | 1.430 |
Why?
| | Postoperative Hemorrhage | 2 | 2026 | 106 | 1.410 |
Why?
| | Tonsillectomy | 2 | 2026 | 106 | 1.320 |
Why?
| | Nasal Polyps | 2 | 2022 | 59 | 1.130 |
Why?
| | Ear | 2 | 2025 | 32 | 1.040 |
Why?
| | Haemophilus influenzae | 2 | 2024 | 68 | 0.980 |
Why?
| | Hearing Aids | 3 | 2025 | 101 | 0.980 |
Why?
| | Congenital Abnormalities | 2 | 2025 | 109 | 0.980 |
Why?
| | Hearing Loss, Conductive | 3 | 2025 | 24 | 0.960 |
Why?
| | Hearing Loss, Sensorineural | 2 | 2024 | 75 | 0.940 |
Why?
| | Ketorolac | 1 | 2026 | 33 | 0.930 |
Why?
| | Hearing Loss | 3 | 2024 | 252 | 0.920 |
Why?
| | Ear Canal | 1 | 2025 | 14 | 0.890 |
Why?
| | Audiometry | 1 | 2025 | 35 | 0.880 |
Why?
| | Meningitis, Haemophilus | 1 | 2023 | 6 | 0.800 |
Why?
| | Haemophilus Infections | 1 | 2024 | 46 | 0.800 |
Why?
| | Child, Preschool | 16 | 2026 | 12017 | 0.780 |
Why?
| | Meningitis, Bacterial | 1 | 2024 | 51 | 0.780 |
Why?
| | Croup | 1 | 2023 | 19 | 0.770 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2026 | 347 | 0.760 |
Why?
| | Child | 24 | 2026 | 22980 | 0.760 |
Why?
| | Turner Syndrome | 1 | 2023 | 65 | 0.740 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2024 | 303 | 0.730 |
Why?
| | Databases, Factual | 3 | 2026 | 1504 | 0.720 |
Why?
| | Deafness | 1 | 2023 | 79 | 0.720 |
Why?
| | Mycoses | 1 | 2022 | 88 | 0.670 |
Why?
| | Retropharyngeal Abscess | 1 | 2020 | 7 | 0.640 |
Why?
| | Mediastinal Diseases | 1 | 2020 | 10 | 0.640 |
Why?
| | Retrospective Studies | 18 | 2026 | 17561 | 0.630 |
Why?
| | Patient Care Team | 1 | 2025 | 712 | 0.600 |
Why?
| | Hemorrhagic Disorders | 1 | 2019 | 10 | 0.590 |
Why?
| | Otitis Media | 3 | 2026 | 185 | 0.590 |
Why?
| | Frontal Sinusitis | 1 | 2018 | 3 | 0.550 |
Why?
| | Orbital Diseases | 1 | 2018 | 37 | 0.530 |
Why?
| | Infant | 11 | 2026 | 10195 | 0.500 |
Why?
| | Blood Coagulation Disorders | 1 | 2019 | 198 | 0.500 |
Why?
| | Speech, Alaryngeal | 1 | 2016 | 3 | 0.490 |
Why?
| | Brain Diseases | 1 | 2018 | 158 | 0.490 |
Why?
| | Punctures | 1 | 2016 | 41 | 0.480 |
Why?
| | Laryngectomy | 1 | 2016 | 17 | 0.480 |
Why?
| | Lymphedema | 1 | 2016 | 22 | 0.470 |
Why?
| | Laryngeal Neoplasms | 1 | 2016 | 36 | 0.470 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2016 | 94 | 0.440 |
Why?
| | Male | 25 | 2026 | 73954 | 0.430 |
Why?
| | Female | 28 | 2026 | 80081 | 0.430 |
Why?
| | Reoperation | 1 | 2018 | 644 | 0.430 |
Why?
| | Eosinophilia | 1 | 2016 | 224 | 0.390 |
Why?
| | Asthma | 2 | 2023 | 1805 | 0.390 |
Why?
| | Humans | 35 | 2026 | 147306 | 0.390 |
Why?
| | Adolescent | 14 | 2026 | 22826 | 0.380 |
Why?
| | Smell | 2 | 2023 | 130 | 0.360 |
Why?
| | Cystic Fibrosis | 1 | 2022 | 1171 | 0.350 |
Why?
| | Cough | 2 | 2023 | 124 | 0.330 |
Why?
| | Staphylococcus aureus | 1 | 2015 | 459 | 0.320 |
Why?
| | Chronic Disease | 4 | 2022 | 1845 | 0.280 |
Why?
| | Trachea | 2 | 2020 | 258 | 0.240 |
Why?
| | Postoperative Complications | 2 | 2026 | 3022 | 0.240 |
Why?
| | Mastoiditis | 1 | 2026 | 10 | 0.240 |
Why?
| | Mastoidectomy | 1 | 2026 | 5 | 0.240 |
Why?
| | Tomography, X-Ray Computed | 4 | 2024 | 2791 | 0.230 |
Why?
| | Ear, Middle | 1 | 2026 | 84 | 0.230 |
Why?
| | Prospective Studies | 4 | 2023 | 8166 | 0.220 |
Why?
| | Interferon Type I | 1 | 2026 | 148 | 0.220 |
Why?
| | Mediastinal Neoplasms | 1 | 2025 | 54 | 0.220 |
Why?
| | Cross-Sectional Studies | 3 | 2023 | 6011 | 0.210 |
Why?
| | Turbinates | 1 | 2024 | 14 | 0.210 |
Why?
| | Coinfection | 1 | 2026 | 143 | 0.210 |
Why?
| | Palatine Tonsil | 1 | 2024 | 55 | 0.210 |
Why?
| | Paranasal Sinuses | 2 | 2016 | 81 | 0.210 |
Why?
| | Constriction, Pathologic | 1 | 2025 | 252 | 0.210 |
Why?
| | Teratoma | 1 | 2025 | 124 | 0.210 |
Why?
| | Hearing Loss, Bilateral | 1 | 2023 | 13 | 0.200 |
Why?
| | Drainage | 2 | 2026 | 189 | 0.200 |
Why?
| | Airway Obstruction | 1 | 2025 | 153 | 0.200 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 173 | 0.200 |
Why?
| | Carcinoma, Acinar Cell | 1 | 2023 | 4 | 0.200 |
Why?
| | Fetal Diseases | 1 | 2025 | 194 | 0.200 |
Why?
| | Adenoma, Pleomorphic | 1 | 2023 | 9 | 0.190 |
Why?
| | Parotid Neoplasms | 1 | 2023 | 15 | 0.190 |
Why?
| | Meningitis, Pneumococcal | 1 | 2023 | 7 | 0.190 |
Why?
| | Adult | 10 | 2025 | 41406 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 102 | 0.190 |
Why?
| | Salivary Gland Neoplasms | 1 | 2023 | 39 | 0.190 |
Why?
| | Odorants | 1 | 2023 | 114 | 0.190 |
Why?
| | Butterflies | 1 | 2023 | 21 | 0.190 |
Why?
| | Steroids | 1 | 2023 | 162 | 0.190 |
Why?
| | Hematopoietic Stem Cells | 1 | 2026 | 435 | 0.180 |
Why?
| | Moths | 1 | 2023 | 45 | 0.180 |
Why?
| | Prevalence | 3 | 2024 | 2889 | 0.180 |
Why?
| | Depression, Postpartum | 1 | 2023 | 117 | 0.170 |
Why?
| | Otolaryngology | 1 | 2023 | 108 | 0.170 |
Why?
| | Fungi | 1 | 2022 | 122 | 0.160 |
Why?
| | Cohort Studies | 2 | 2025 | 6099 | 0.160 |
Why?
| | Granuloma, Pyogenic | 1 | 2020 | 10 | 0.160 |
Why?
| | Mediastinum | 1 | 2020 | 23 | 0.160 |
Why?
| | Neutrophils | 1 | 2026 | 1135 | 0.160 |
Why?
| | Head and Neck Neoplasms | 1 | 2025 | 569 | 0.160 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 487 | 0.150 |
Why?
| | Surgery, Computer-Assisted | 1 | 2020 | 86 | 0.150 |
Why?
| | Partial Thromboplastin Time | 1 | 2019 | 53 | 0.150 |
Why?
| | Cellulitis | 1 | 2019 | 54 | 0.140 |
Why?
| | RNA, Viral | 1 | 2022 | 695 | 0.140 |
Why?
| | Laser Therapy | 1 | 2020 | 146 | 0.140 |
Why?
| | Necrosis | 1 | 2019 | 245 | 0.140 |
Why?
| | Electronic Health Records | 1 | 2026 | 1214 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2025 | 11947 | 0.130 |
Why?
| | Cocaine-Related Disorders | 1 | 2019 | 133 | 0.130 |
Why?
| | Microbiota | 2 | 2016 | 736 | 0.130 |
Why?
| | Disease Progression | 1 | 2025 | 2892 | 0.130 |
Why?
| | Speech Intelligibility | 1 | 2016 | 4 | 0.120 |
Why?
| | RNA, Bacterial | 2 | 2016 | 182 | 0.120 |
Why?
| | Glottis | 1 | 2016 | 20 | 0.120 |
Why?
| | Tracheal Diseases | 1 | 2016 | 15 | 0.120 |
Why?
| | Bronchial Diseases | 1 | 2016 | 38 | 0.120 |
Why?
| | Jugular Veins | 1 | 2016 | 42 | 0.120 |
Why?
| | Laryngeal Diseases | 1 | 2016 | 31 | 0.120 |
Why?
| | Amyloidosis | 1 | 2016 | 45 | 0.120 |
Why?
| | Neck | 1 | 2016 | 109 | 0.110 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2016 | 222 | 0.110 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2016 | 512 | 0.110 |
Why?
| | Gentamicins | 1 | 2015 | 50 | 0.110 |
Why?
| | Drug Hypersensitivity | 1 | 2016 | 93 | 0.110 |
Why?
| | Calcinosis | 1 | 2016 | 234 | 0.100 |
Why?
| | Esophagus | 1 | 2016 | 262 | 0.100 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 48 | 0.100 |
Why?
| | Young Adult | 2 | 2023 | 14437 | 0.100 |
Why?
| | Nasal Cavity | 1 | 2013 | 61 | 0.100 |
Why?
| | Acute Disease | 2 | 2026 | 1049 | 0.100 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1281 | 0.100 |
Why?
| | Cervical Rib Syndrome | 1 | 2012 | 1 | 0.100 |
Why?
| | Cervical Rib | 1 | 2012 | 1 | 0.100 |
Why?
| | Streptococcus pneumoniae | 2 | 2026 | 190 | 0.090 |
Why?
| | Aspirin | 1 | 2016 | 406 | 0.090 |
Why?
| | Signal Transduction | 1 | 2026 | 5272 | 0.090 |
Why?
| | Middle Aged | 6 | 2019 | 36821 | 0.090 |
Why?
| | Risk Factors | 3 | 2026 | 11017 | 0.090 |
Why?
| | United States | 2 | 2026 | 16313 | 0.080 |
Why?
| | Cervical Vertebrae | 1 | 2012 | 170 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2020 | 5478 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2974 | 0.080 |
Why?
| | Inflammation | 1 | 2022 | 2921 | 0.080 |
Why?
| | Recurrence | 2 | 2026 | 1151 | 0.080 |
Why?
| | Aged | 4 | 2016 | 26516 | 0.070 |
Why?
| | Risk Assessment | 1 | 2016 | 3784 | 0.060 |
Why?
| | Middle Ear Ventilation | 1 | 2026 | 18 | 0.060 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2026 | 35 | 0.060 |
Why?
| | Extracellular Traps | 1 | 2026 | 53 | 0.060 |
Why?
| | Time Factors | 1 | 2016 | 7173 | 0.050 |
Why?
| | Phagocytosis | 1 | 2026 | 299 | 0.050 |
Why?
| | Nasal Septum | 1 | 2024 | 30 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 90 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2016 | 8432 | 0.050 |
Why?
| | Parotid Gland | 1 | 2023 | 17 | 0.050 |
Why?
| | Submandibular Gland | 1 | 2023 | 20 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 1 | 2025 | 295 | 0.050 |
Why?
| | Vaccines, Conjugate | 1 | 2023 | 60 | 0.050 |
Why?
| | Down-Regulation | 1 | 2024 | 618 | 0.040 |
Why?
| | Edema | 1 | 2023 | 128 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2023 | 130 | 0.040 |
Why?
| | Larva | 1 | 2023 | 242 | 0.040 |
Why?
| | Hearing | 1 | 2023 | 133 | 0.040 |
Why?
| | Bone Conduction | 1 | 2020 | 27 | 0.040 |
Why?
| | Eating | 1 | 2023 | 387 | 0.040 |
Why?
| | Diagnosis, Differential | 2 | 2016 | 1518 | 0.040 |
Why?
| | Vomiting | 1 | 2020 | 131 | 0.040 |
Why?
| | Face | 1 | 2019 | 176 | 0.030 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 231 | 0.030 |
Why?
| | Mothers | 1 | 2023 | 774 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1342 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3660 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2026 | 1940 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2026 | 6042 | 0.030 |
Why?
| | Laryngoscopy | 1 | 2016 | 122 | 0.030 |
Why?
| | Bronchoscopy | 1 | 2016 | 228 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 395 | 0.030 |
Why?
| | Pneumonia | 1 | 2020 | 636 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2025 | 6543 | 0.020 |
Why?
| | Biomarkers | 1 | 2024 | 4354 | 0.020 |
Why?
| | Neck Pain | 1 | 2012 | 35 | 0.020 |
Why?
| | Pregnancy | 1 | 2025 | 7276 | 0.020 |
Why?
| | Animals | 2 | 2026 | 38417 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 2012 | 173 | 0.020 |
Why?
| | Bacteria | 1 | 2016 | 769 | 0.020 |
Why?
| | Mice | 1 | 2026 | 18493 | 0.020 |
Why?
|
|
Gitomer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|